SCHEMBL13689396

SCHEMBL13689396

CN(CC(c1ccccc1)c1ccccc1)C(=O)[C@H](Cc1cccnc1)NCCNC(=O)c1ccc2ccccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.45
▸ TMEM97 Q5BJF2 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ NAMPT P43490 2/20 0.44
▸ DRD4 P21917 1/20 0.43
▸ PTAFR P25105 2/20 0.42
▸ EPHX2 P34913 3/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ PLD2 O14939 1/20 0.41
▸ FOLH1 Q04609 1/20 0.41
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ RAB9A P51151 2/20 0.39
▸ MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13188836 0.81 NPC1 (0.46) OPRM1TMEM97SIGMAR1DRD4NPC1
SCHEMBL13691772 0.80 OPRM1 (0.46) OPRM1TMEM97SIGMAR1DRD4NPC1
SCHEMBL13691769 0.79 OPRM1 (0.46) OPRM1TMEM97SIGMAR1DRD4NPC1
SCHEMBL13689401 0.78 OPRM1 (0.45) OPRM1TMEM97SIGMAR1DRD4NPC1
SCHEMBL13689398 0.77 NPC1 (0.44) OPRM1TMEM97SIGMAR1NAMPTDRD4
SCHEMBL13691768 0.76 OPRM1 (0.45) OPRM1TMEM97SIGMAR1NPC1RAB9A
SCHEMBL13691797 0.76 DRD2 (0.54) OPRM1TMEM97SIGMAR1DRD4CYP2C19
SCHEMBL13689397 0.74 CXCR4 (0.43) OPRM1TMEM97SIGMAR1DRD4NPC1
SCHEMBL13188839 0.72 TMEM97 (0.42) OPRM1TMEM97SIGMAR1DRD4EPHX2
SCHEMBL13691793 0.69 NPC1 (0.47) OPRM1TMEM97SIGMAR1DRD4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009105824-A1 METHODS OF MODULATING THE ACTIVITY OF THE MC5 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR MIMETICA PTY LTD (AU) 2009-09-03 — — WO disclosed
Send feedback